(Q38025012)

27 August 2017

title

Gene and cytokine therapy for heart failure: molecular mechanisms in the improvement of cardiac function (English)

1 reference

27 August 2017

2

Issei Komuro

1 reference

27 August 2017

Toshio Nagai

1

1 reference

27 August 2017

publication date

9 July 2012

1 reference

American Journal of Physiology Heart and Circulatory Physiology

27 August 2017

published in

1 reference

27 August 2017

volume

303

1 reference

27 August 2017

issue

5

1 reference

27 August 2017

page(s)

H501-12

1 reference

Granulocyte colony-stimulating factor therapy for cardiac repair after acute myocardial infarction: a systematic review and meta-analysis of randomized controlled trials

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Darbepoetin alfa protects the rat heart against infarction: dose-response, phase of action, and mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Gene delivery of sarcoplasmic reticulum calcium ATPase inhibits ventricular remodeling in ischemic mitral regurgitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Cardiac excitation-contraction coupling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Calcium cycling and signaling in cardiac myocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Cardiac gene transfer of short hairpin RNA directed against phospholamban effectively knocks down gene expression but causes cellular toxicity in canines

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

S100A1 genetically targeted therapy reverses dysfunction of human failing cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

beta-adrenergic receptor blockade in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Erythropoietin activates mitochondrial biogenesis and couples red cell mass to mitochondrial mass in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Constitutive cardiac overexpression of sarcoplasmic/endoplasmic reticulum Ca2+-ATPase delays myocardial failure after myocardial infarction in rats at a cost of increased acute arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Endocytosis of G protein-coupled receptors: roles of G protein-coupled receptor kinases and beta-arrestin proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Improvement in survival and cardiac metabolism after gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase in a rat model of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Abrogation of ventricular arrhythmias in a model of ischemia and reperfusion by targeting myocardial calcium cycling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Hematopoietic stem cells do not repair the infarcted mouse heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Manipulating cardiac contractility in heart failure: data from mice and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Beta-adrenergic stimulation and myocardial function in the failing heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Inotropic therapy for heart failure: an evidence-based approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Administration of granulocyte colony-stimulating factor after myocardial infarction enhances the recruitment of hematopoietic stem cell-derived myofibroblasts and contributes to cardiac repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Unanticipated signaling events associated with cardiac adenylyl cyclase gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Paracrine mechanisms in adult stem cell signaling and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Adenylyl cyclases: structure, regulation and function in an enzyme superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Cardiac beta ARK1 inhibition prolongs survival and augments beta blocker therapy in a mouse model of severe heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Calcium cycling in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Erythropoietin induces positive inotropic and lusitropic effects in murine and human myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Granulocyte colony-stimulating factor protects cardiac mitochondria in the early phase of cardiac injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Comparative analysis of parvalbumin and SERCA2a cardiac myocyte gene transfer in a large animal model of diastolic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Erythropoietin preserves the endothelial differentiation capacity of cardiac progenitor cells and reduces heart failure during anticancer therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Is depressed myocyte contractility centrally involved in heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Preservation from left ventricular remodeling by front-integrated revascularization and stem cell liberation in evolving acute myocardial infarction by use of granulocyte-colony-stimulating factor (FIRSTLINE-AMI)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Phospholamban gene ablation improves calcium transients but not cardiac function in a heart failure model

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1/2 clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Effectiveness and tolerability of administration of granulocyte colony-stimulating factor on left ventricular function in patients with myocardial infarction: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

AAV6-βARKct gene delivery mediated by molecular cardiac surgery with recirculating delivery (MCARD) in sheep results in robust gene expression and increased adrenergic reserve

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Rescuing the failing heart by targeted gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Percutaneous cardiac recirculation-mediated gene transfer of an inhibitory phospholamban peptide reverses advanced heart failure in large animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Enhanced cardiac function in mice overexpressing protein phosphatase Inhibitor-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Erythropoietin as a treatment of anemia in heart failure: systematic review of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Intracoronary adenovirus encoding adenylyl cyclase VI increases left ventricular function in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Gene therapy for ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Safety of granulocyte-colony-stimulating factor in acute myocardial infarction (the Rigenera study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Role of cardiac stem cells in cardiac pathophysiology: a paradigm shift in human myocardial biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Treatment with granulocyte colony-stimulating factor ameliorates chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Adrenal adrenoceptors in heart failure: fine-tuning cardiac stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Cardiac myosin activation part 1: from concept to clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Recent advances in lentiviral vector development and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Design and rationale of the Reduction of Infarct Expansion and Ventricular Remodeling with Erythropoietin after Large Myocardial Infarction (REVEAL) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Erythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

S100A1: a regulator of myocardial contractility

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Transgenic overexpression of the Ca2+-binding protein S100A1 in the heart leads to increased in vivo myocardial contractile performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Cardiac adenoviral S100A1 gene delivery rescues failing myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Cardiac S100A1 protein levels determine contractile performance and propensity toward heart failure after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

S100A1: a novel inotropic regulator of cardiac performance. Transition from molecular physiology to pathophysiological relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Mobilized bone marrow cells repair the infarcted heart, improving function and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Erythropoietin in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomized, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

G-CSF exerts dual effects on endothelial cells--opposing actions of direct eNOS induction versus indirect CRP elevation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

A novel protective effect of erythropoietin in the infarcted heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

The β-adrenergic receptor kinase in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Adenylyl cyclase and G protein receptor kinase expression during development of heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Stable myocardial-specific AAV6-S100A1 gene therapy results in chronic functional heart failure rescue

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Cardiac AAV9-S100A1 gene therapy rescues post-ischemic heart failure in a preclinical large animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Adenylylcyclase gene transfer increases function of the failing heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Altered expression of the Ca(2+)-binding protein S100A1 in human cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Myocardial adeno-associated virus serotype 6-betaARKct gene therapy improves cardiac function and normalizes the neurohormonal axis in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Stem Cell Mobilization Induced by Subcutaneous Granulocyte-Colony Stimulating Factor to Improve Cardiac Regeneration After Acute ST-Elevation Myocardial Infarction: Result of the Double-Blind, Randomized, Placebo-Controlled Stem Cells in Myocardial I

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Expression of a beta-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Seven-transmembrane-spanning receptors and heart function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

S100A1 gene therapy for heart failure: A novel strategy on the verge of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Cardiac-directed adenylyl cyclase expression improves heart function in murine cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Indirect intracoronary delivery of adenovirus encoding adenylyl cyclase increases left ventricular contractile function in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Restoration of mechanical and energetic function in failing aortic-banded rat hearts by gene transfer of calcium cycling proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Rescue of contractile parameters and myocyte hypertrophy in calsequestrin overexpressing myocardium by phospholamban ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Neuregulin-1β for the treatment of systolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Recombinant adeno-associated virus transduction and integration

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

In vivo ventricular gene delivery of a beta-adrenergic receptor kinase inhibitor to the failing heart reverses cardiac dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Reversal of cardiac myocyte dysfunction as a unique mechanism of rescue by P2X4 receptors in cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Acute cardioprotective effects of erythropoietin in infant rabbits are mediated by activation of protein kinases and potassium channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Rescue of cardiomyocyte dysfunction by phospholamban ablation does not prevent ventricular failure in genetic hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Increased cardiac adenylyl cyclase expression is associated with increased survival after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

G-CSF therapy for acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

The myocardial protein S100A1 plays a role in the maintenance of normal gene expression in the adult heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Rescue of Ca2+ overload-induced left ventricular dysfunction by targeted ablation of phospholamban

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Sonic hedgehog is a critical mediator of erythropoietin-induced cardiac protection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

A single dose of erythropoietin in ST-elevation myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Targeted beta-adrenergic receptor kinase (betaARK1) inhibition by gene transfer in failing human hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Cell therapy for the treatment of coronary heart disease: a critical appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Inhibition of protein phosphatase 1 by inhibitor-2 gene delivery ameliorates heart failure progression in genetic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Novel polymer carriers and gene constructs for treatment of myocardial ischemia and infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

Stem cell mobilization by granulocyte colony-stimulating factor for myocardial recovery after acute myocardial infarction: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00130.2012

10.1152/AJPHEART.00130.2012

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference